Biotech · Private company
Elan Pharmaceuticals
Track this companyFree. Adds Elan Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without DementiaPHASE2 · COMPLETED · started Sep 1, 2013ClinicalTrials.gov NCT01791725 · fetched Nov 12, 2026
- A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseasePHASE2 · TERMINATED · started Jan 1, 2013ClinicalTrials.gov NCT01766336 · fetched Nov 12, 2026
- Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseasePHASE2 · COMPLETED · started Nov 1, 2012ClinicalTrials.gov NCT01735630 · fetched Nov 12, 2026
- Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I DisorderPHASE2 · TERMINATED · started Aug 1, 2012ClinicalTrials.gov NCT01674010 · fetched Nov 12, 2026
- Evaluation of Natalizumab for thE Relief of MS Associated FatiGueCOMPLETED · started Aug 1, 2007ClinicalTrials.gov NCT00464074 · fetched Nov 12, 2026
- ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus InfectionsPHASE2 · COMPLETED · started Oct 1, 2001ClinicalTrials.gov NCT00035945 · fetched Nov 12, 2026